MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
2.815
+0.045
+1.62%
Opening 09:38 07/25 EDT
OPEN
2.780
PREV CLOSE
2.770
HIGH
2.840
LOW
2.780
VOLUME
9.35K
TURNOVER
0
52 WEEK HIGH
5.13
52 WEEK LOW
2.145
MARKET CAP
90.10M
P/E (TTM)
-7.6184
1D
5D
1M
3M
1Y
5Y
1D
Buy Rating Affirmed for Anixa Biosciences Amid Promising Cancer Therapy Trials
TipRanks · 1d ago
ANIXA BIOSCIENCES ANNOUNCES FDA APPROVAL OF INDIVIDUAL PATIENT IND FOR ITS OVARIAN CANCER CAR-T THERAPY
Reuters · 2d ago
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
Anixa Biosciences has received FDA approval for a CAR-T therapy for an individual patient. Anixa has authorized a share repurchase program of up to $5 million. The company's collaborator, Moffit Cancer Center, is treating ovarian cancer patients.
Benzinga · 2d ago
Weekly Report: what happened at ANIX last week (0715-0719)?
Weekly Report · 3d ago
ANIXA BIOSCIENCES INC - VACCINE CURRENTLY BEING STUDIED IN PHASE ONE CLINICAL TRIAL AT CLEVELAND CLINIC
Reuters · 07/17 12:00
ANIXA BIOSCIENCES ANNOUNCES JAPANESE PATENT ON BREAST CANCER VACCINE TECHNOLOGY
Reuters · 07/17 12:00
Anixa Biosciences authorizes $5M share buyback program
Seeking Alpha · 07/15 12:43
Press Release: Anixa Biosciences Announces $5 Million Share Repurchase Program
Dow Jones · 07/15 12:30
More
About ANIX
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.